中华疾病控制杂志2020年4月第24卷第4期 Chin j Dis Control Prev2020Apr;24(4) 379 Transl Med, 2014, 6( 224): 224ra224. Dol: 10. 1 126/scitrans- Screening for breast cancer and cervical cancer [J].Chinese lmed.3007094. Health,2019,(10):54. [44] Church TR, Wandell M, Lofton-Day C, et al. Prospective evalua- [54] Xiao HF, Yan SP, Chen YF, et al. Community-based upper gas- tion of methylated SEPT9 in plasma for detection of asymptomatie trointestinal screening in a randomized controlled trial colorectal cancer [J]. Gut, 2014, 63(2): 317-325. DO1: 10 baseline results in a non-high-incidence area [J].Cancer Prev l136/ guting-2012-304149 Res( Phila),2020,13(3):317-328.DOl:10.1158/1940-6207 [45 Choi KS, Kwak MS, Lee HY, et al. Screening for gastric cancer Korea: population-based preferences for endoscopy versus upper [55] Chen W, Zeng H, Chen R, et al. Evaluating efficacy of screening gastrointestinal series [J]. Cancer Epidemiol Biomarkers Prev upper gastrointestinal cancer in China: a study protocol for 009,18(5):1390-1398.DOl:10.1158/1055-9965.EPl-08 domized controlled trial [J]. Chin J Cancer Res, 2017, 29 (4):294-302.DOl:10.21147/isn.1000-9604.2017.04.02. [46] Hamashima C. Cancer screening guidelines and policy making: 15 [56] Chen H, Li N, Ren J, et al. Participation and yield of a popula- years of experience in cancer screening guideline development in Japan [J].Jpn J Clin Oncol, 2018, 48(3): 278-286. DO1: 10 Cut,2019,68(8):1450-1457.DOl:10.1136/gujn-2018 [47] National Lung Screening Trial Research T, Church TR, Black [57] He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for e- WC, et al. Results of initial low -dose computed tomographic sophageal cancer in China(ESECC): design and preliminary re screening for lung cancer [J]. N Engl J Med, 2013, 368(21) ults of a population-based randomised controlled trial [J].Gu 1980-1991.DOl:10.1056/ NEMO1209120. 019,68(2):198-206.DOl:10.1136/ guting-2017-315520. [48 Vale DB, Anttila A, Ponti A, et al. Invitation strategies and co- [58 Chen H, Li N, Shi J, et al. Comparative evaluation of nove rage in the population-based cancer screening programmes in the screening strategies for colorectal cancer screening in China(TAR- European Union [J]. Eur J Cancer Prev, 2019,28(2): 131-140 GET-C): a study protocol for a multicentre randomised controlled DOl:10.1097/CEJ.00000000006. tial[J]. BMJ Open,2019,9(4):025935.DOl:10.1136/bm [49 Parkin CJ, Bell SW, Mirbugheri N. Colorectal ustralia: An update[J]. Aust J Gen Pract,2018,47(12):859-[59]中华人民共和国国务院.健康中国行动(2019-2030年) 863.DOl:10.31128/AJGP01-18-4472 [EB/OL].(2019-7-15)[2020-3-02].hp://ww.gw.cm [50]Zhou Q. MS16.02 NELCIN B3 screening program in China [J] xinwen/2019-07/15/content 5409694 htm Journal of Thoracic Oncology, 2018, 13( 10, Supplement ): $272- State Council of the People's Republic of China. Healthy China ac- S273.DO1:10.1016/ i- the.2018.08.154 ion(2019-2030)[EB/OL].(2019-07-15)[2020-03-02] [51]代敏,石菊芳,李霓.中国城市癌症早诊早治项目设计及预期 目标[门]中华预防医学杂志,2013,47(2):179-182.DOl:[60]中华人民共和国国家卫生健康委员会关于印发健康中国行 10.3760/ cma.J.Issn.0253-9624.2013.02.018 动——癌症防治实施方案(2019-2022年)的通知[EB/OL] Dai M, Shi JF, Li N. Design and expected goal of (2019-09-23)[2020-03-02].htp://ww.nhe.gocm/jky ing program in urban China [J]. Chin J Prevent Med, 2013, 47 s5878/201909/2cb5dfh5d4f84f8881897e232b376b60. shtml (2):179-182.DOl:10.3760/ sn.0253-9624.2013 of China 018 Notice on printing and distributing health China action -cancer [52]陈万青,曹毛毛。加强癌症早诊早治,实施健康中国战略[J prevention and control implementation plan(2019- 2022)[EB/ 中国肿瘤,2019,28(9):643.DO1:10.11735/isn.1004-0242. OL].(2019-9-23)[2020-3-02].hpe://w.nhe.gov.c 2019.09.AOOl jkys5878/201909/2ch5dbsd48488897c232b376b60. shtml Chen wQ, Cao MM. Strengthening cancer early diagnosis and (收稿日期:2020-03-19) treatment,implementing the strategy of healthy China [J].China (修回日期:2020-04-01) Cancer,2019,28(9):643.DOl:10.11735/jisn.1004-0242. 本文编辑:范安琪(中文) 2019.09.AOOl 潘海峰(英文) [53]“两癌”筛查[J].中国卫生,2019,(10):54Ｔｒａｎｓｌ Ｍｅｄꎬ ２０１４ꎬ ６ ( ２２４): ２２４ｒａ２２４. ＤＯＩ: １０. １１２６ / ｓｃｉｔｒａｎｓ￣ ｌｍｅｄ.３００７０９４. [ ４４] Ｃｈｕｒｃｈ ＴＲꎬ Ｗａｎｄｅｌｌ Ｍꎬ Ｌｏｆｔｏｎ－Ｄａｙ Ｃꎬ ｅｔ ａｌ. Ｐｒｏｓｐｅｃｔｉｖｅ ｅｖａｌｕａ￣ ｔｉｏｎ ｏｆ ｍｅｔｈｙｌａｔｅｄ ＳＥＰＴ９ ｉｎ ｐｌａｓｍａ ｆｏｒ ｄｅｔｅｃｔｉｏｎ ｏｆ ａｓｙｍｐｔｏｍａｔｉｃ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ [ Ｊ]. Ｇｕｔꎬ ２０１４ꎬ６３ ( ２): ３１７ － ３２５. ＤＯＩ: １０. １１３６ / ｇｕｔｊｎｌ－２０１２－３０４１４９. [ ４５] Ｃｈｏｉ ＫＳꎬ Ｋｗａｋ ＭＳꎬ Ｌｅｅ ＨＹꎬ ｅｔ ａｌ. Ｓｃｒｅｅｎｉｎｇ ｆｏｒ ｇａｓｔｒｉｃ ｃａｎｃｅｒ ｉｎ Ｋｏｒｅａ: ｐｏｐｕｌａｔｉｏｎ－ｂａｓｅｄ ｐｒｅｆｅｒｅｎｃｅｓ ｆｏｒ ｅｎｄｏｓｃｏｐｙ ｖｅｒｓｕｓ ｕｐｐｅｒ ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌ ｓｅｒｉｅｓ [ Ｊ]. Ｃａｎｃｅｒ Ｅｐｉｄｅｍｉｏｌ Ｂｉｏｍａｒｋｅｒｓ Ｐｒｅｖꎬ ２００９ꎬ１８(５):１３９０－ １３９８. ＤＯＩ:１０.１１５８ / １０５５－ ９９６５.ＥＰＩ－ ０８ － ０９４０. [４６] Ｈａｍａｓｈｉｍａ Ｃ. Ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｇｕｉｄｅｌｉｎｅｓ ａｎｄ ｐｏｌｉｃｙ ｍａｋｉｎｇ: １５ ｙｅａｒｓ ｏｆ ｅｘｐｅｒｉｅｎｃｅ ｉｎ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｇｕｉｄｅｌｉｎｅ ｄｅｖｅｌｏｐｍｅｎｔ ｉｎ Ｊａｐａｎ [Ｊ]. Ｊｐｎ Ｊ Ｃｌｉｎ Ｏｎｃｏｌꎬ ２０１８ꎬ４８( ３):２７８－ ２８６. ＤＯＩ:１０. １０９３ / ｊｊｃｏ / ｈｙｘ１９０. [４７] Ｎａｔｉｏｎａｌ Ｌｕｎｇ Ｓｃｒｅｅｎｉｎｇ Ｔｒｉａｌ Ｒｅｓｅａｒｃｈ Ｔꎬ Ｃｈｕｒｃｈ ＴＲꎬ Ｂｌａｃｋ ＷＣꎬ ｅｔ ａｌ. Ｒｅｓｕｌｔｓ ｏｆ ｉｎｉｔｉａｌ ｌｏｗ － ｄｏｓｅ ｃｏｍｐｕｔｅｄ ｔｏｍｏｇｒａｐｈｉｃ ｓｃｒｅｅｎｉｎｇ ｆｏｒ ｌｕｎｇ ｃａｎｃｅｒ [ Ｊ]. Ｎ Ｅｎｇｌ Ｊ Ｍｅｄꎬ ２０１３ꎬ３６８( ２１): １９８０－１９９１. ＤＯＩ:１０.１０５６ / ＮＥＪＭｏａ１２０９１２０. [４８] Ｖａｌｅ ＤＢꎬ Ａｎｔｔｉｌａ Ａꎬ Ｐｏｎｔｉ Ａꎬ ｅｔ ａｌ. Ｉｎｖｉｔａｔｉｏｎ ｓｔｒａｔｅｇｉｅｓ ａｎｄ ｃｏｖ￣ ｅｒａｇｅ ｉｎ ｔｈｅ ｐｏｐｕｌａｔｉｏｎ－ｂａｓｅｄ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｐｒｏｇｒａｍｍｅｓ ｉｎ ｔｈｅ Ｅｕｒｏｐｅａｎ Ｕｎｉｏｎ [Ｊ]. Ｅｕｒ Ｊ Ｃａｎｃｅｒ Ｐｒｅｖꎬ ２０１９ꎬ２８(２):１３１－１４０. ＤＯＩ:１０.１０９７ / ＣＥＪ.０００００００００００００４２６. [４９] Ｐａｒｋｉｎ ＣＪꎬ Ｂｅｌｌ ＳＷꎬ Ｍｉｒｂａｇｈｅｒｉ Ｎ. Ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｉｎ Ａｕｓｔｒａｌｉａ: Ａｎ ｕｐｄａｔｅ [Ｊ]. Ａｕｓｔ Ｊ Ｇｅｎ Ｐｒａｃｔꎬ ２０１８ꎬ４７(１２):８５９－ ８６３. ＤＯＩ:１０.３１１２８ / ＡＪＧＰ￣０１￣１８￣４４７２. [５０] Ｚｈｏｕ Ｑ. ＭＳ１６.０２ ＮＥＬＣＩＮ Ｂ３ ｓｃｒｅｅｎｉｎｇ ｐｒｏｇｒａｍ ｉｎ Ｃｈｉｎａ [ Ｊ]. Ｊｏｕｒｎａｌ ｏｆ Ｔｈｏｒａｃｉｃ Ｏｎｃｏｌｏｇｙꎬ ２０１８ꎬ１３(１０ꎬ Ｓｕｐｐｌｅｍｅｎｔ):Ｓ２７２－ Ｓ２７３. ＤＯＩ:１０.１０１６ / ｊ.ｊｔｈｏ.２０１８.０８.１５４. [５１] 代敏ꎬ 石菊芳ꎬ 李霓. 中国城市癌症早诊早治项目设计及预期 目标 [Ｊ]. 中华预防医学杂志ꎬ ２０１３ꎬ４７( ２):１７９－ １８２. ＤＯＩ: １０.３７６０ / ｃｍａ.ｊ.ｉｓｓｎ.０２５３－９６２４.２０１３.０２.０１８ Ｄａｉ Ｍꎬ Ｓｈｉ ＪＦꎬ Ｌｉ Ｎ. Ｄｅｓｉｇｎ ａｎｄ ｅｘｐｅｃｔｅｄ ｇｏａｌ ｏｆ ｃａｎｃｅｒ ｓｃｒｅｅｎ￣ ｉｎｇ ｐｒｏｇｒａｍ ｉｎ ｕｒｂａｎ Ｃｈｉｎａ [ Ｊ]. Ｃｈｉｎ Ｊ Ｐｒｅｖｅｎｔ Ｍｅｄꎬ ２０１３ꎬ４７ (２):１７９ － １８２. ＤＯＩ:１０. ３７６０ / ｃｍａ. ｊ. ｉｓｓｎ. ０２５３ － ９６２４. ２０１３. ０２. ０１８. [５２] 陈万青ꎬ 曹毛毛. 加强癌症早诊早治ꎬ实施健康中国战略 [ Ｊ]. 中国肿瘤ꎬ ２０１９ꎬ２８(９):６４３. ＤＯＩ:１０.１１７３５ / ｊ.ｉｓｓｎ.１００４－０２４２. ２０１９.０９.Ａ００１ Ｃｈｅｎ ＷＱꎬ Ｃａｏ ＭＭ. Ｓｔｒｅｎｇｔｈｅｎｉｎｇ ｃａｎｃｅｒ ｅａｒｌｙ ｄｉａｇｎｏｓｉｓ ａｎｄ ｔｒｅａｔｍｅｎｔꎬ ｉｍｐｌｅｍｅｎｔｉｎｇ ｔｈｅ ｓｔｒａｔｅｇｙ ｏｆ ｈｅａｌｔｈｙ Ｃｈｉｎａ [ Ｊ]. Ｃｈｉｎａ Ｃａｎｃｅｒꎬ ２０１９ꎬ２８ ( ９):６４３. ＤＯＩ: １０. １１７３５ / ｊ. ｉｓｓｎ. １００４ － ０２４２. ２０１９.０９.Ａ００１. [５３] “两癌”筛查 [Ｊ]. 中国卫生ꎬ ２０１９ꎬ(１０):５４. Ｓｃｒｅｅｎｉｎｇ ｆｏｒ ｂｒｅａｓｔ ｃａｎｃｅｒ ａｎｄ ｃｅｒｖｉｃａｌ ｃａｎｃｅｒ [ Ｊ ]. Ｃｈｉｎｅｓｅ Ｈｅａｌｔｈꎬ ２０１９ꎬ(１０):５４. [５４] Ｘｉａｏ ＨＦꎬ Ｙａｎ ＳＰꎬ Ｃｈｅｎ ＹＦꎬ ｅｔ ａｌ. Ｃｏｍｍｕｎｉｔｙ－ｂａｓｅｄ ｕｐｐｅｒ ｇａｓ￣ ｔｒｏｉｎｔｅｓｔｉｎａｌ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｉｎ ａ ｒａｎｄｏｍｉｚｅｄ ｃｏｎｔｒｏｌｌｅｄ ｔｒｉａｌ: ｂａｓｅｌｉｎｅ ｒｅｓｕｌｔｓ ｉｎ ａ ｎｏｎ－ｈｉｇｈ－ｉｎｃｉｄｅｎｃｅ ａｒｅａ [ Ｊ]. Ｃａｎｃｅｒ Ｐｒｅｖ Ｒｅｓ (Ｐｈｉｌａ)ꎬ ２０２０ꎬ１３(３):３１７－３２８. ＤＯＩ:１０.１１５８ / １９４０－６２０７. ｃａｐｒ－１９－０４２２. [５５] Ｃｈｅｎ Ｗꎬ Ｚｅｎｇ Ｈꎬ Ｃｈｅｎ Ｒꎬ ｅｔ ａｌ. Ｅｖａｌｕａｔｉｎｇ ｅｆｆｉｃａｃｙ ｏｆ ｓｃｒｅｅｎｉｎｇ ｆｏｒ ｕｐｐｅｒ ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌ ｃａｎｃｅｒ ｉｎ Ｃｈｉｎａ: ａ ｓｔｕｄｙ ｐｒｏｔｏｃｏｌ ｆｏｒ ａ ｒａｎｄｏｍｉｚｅｄ ｃｏｎｔｒｏｌｌｅｄ ｔｒｉａｌ [ Ｊ]. Ｃｈｉｎ Ｊ Ｃａｎｃｅｒ Ｒｅｓꎬ ２０１７ꎬ ２９ (４):２９４－３０２. ＤＯＩ:１０.２１１４７ / ｊ.ｉｓｓｎ.１０００－９６０４.２０１７.０４.０２. [５６] Ｃｈｅｎ Ｈꎬ Ｌｉ Ｎꎬ Ｒｅｎ Ｊꎬ ｅｔ ａｌ. Ｐａｒｔｉｃｉｐａｔｉｏｎ ａｎｄ ｙｉｅｌｄ ｏｆ ａ ｐｏｐｕｌａ￣ ｔｉｏｎ－ｂａｓｅｄ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｐｒｏｇｒａｍｍｅ ｉｎ Ｃｈｉｎａ [ Ｊ]. Ｇｕｔꎬ ２０１９ꎬ６８ ( ８): １４５０ － １４５７. ＤＯＩ: １０. １１３６ / ｇｕｔｊｎｌ － ２０１８ － ３１７１２４. [５７] Ｈｅ Ｚꎬ Ｌｉｕ Ｚꎬ Ｌｉｕ Ｍꎬ ｅｔ ａｌ. Ｅｆｆｉｃａｃｙ ｏｆ ｅｎｄｏｓｃｏｐｉｃ ｓｃｒｅｅｎｉｎｇ ｆｏｒ ｅ￣ ｓｏｐｈａｇｅａｌ ｃａｎｃｅｒ ｉｎ Ｃｈｉｎａ (ＥＳＥＣＣ): ｄｅｓｉｇｎ ａｎｄ ｐｒｅｌｉｍｉｎａｒｙ ｒｅ￣ ｓｕｌｔｓ ｏｆ ａ ｐｏｐｕｌａｔｉｏｎ－ｂａｓｅｄ ｒａｎｄｏｍｉｓｅｄ ｃｏｎｔｒｏｌｌｅｄ ｔｒｉａｌ [ Ｊ]. Ｇｕｔꎬ ２０１９ꎬ６８(２):１９８－２０６. ＤＯＩ:１０.１１３６ / ｇｕｔｊｎｌ－２０１７－３１５５２０. [５８] Ｃｈｅｎ Ｈꎬ Ｌｉ Ｎꎬ Ｓｈｉ Ｊꎬ ｅｔ ａｌ. Ｃｏｍｐａｒａｔｉｖｅ ｅｖａｌｕａｔｉｏｎ ｏｆ ｎｏｖｅｌ ｓｃｒｅｅｎｉｎｇ ｓｔｒａｔｅｇｉｅｓ ｆｏｒ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｓｃｒｅｅｎｉｎｇ ｉｎ Ｃｈｉｎａ (ＴＡＲ￣ ＧＥＴ－Ｃ): ａ ｓｔｕｄｙ ｐｒｏｔｏｃｏｌ ｆｏｒ ａ ｍｕｌｔｉｃｅｎｔｒｅ ｒａｎｄｏｍｉｓｅｄ ｃｏｎｔｒｏｌｌｅｄ ｔｒｉａｌ [Ｊ]. ＢＭＪ Ｏｐｅｎꎬ ２０１９ꎬ９( ４):ｅ０２５９３５. ＤＯＩ:１０.１１３６ / ｂｍ￣ ｊｏｐｅｎ－２０１８－０２５９３５. [５９] 中华人民共和国国务院. 健康中国行动 ( ２０１９—２０３０ 年) [ＥＢ/ ＯＬ]. (２０１９－７－ １５) [ ２０２０－ ３－ ０２]. ｈｔｔｐ: / / ｗｗｗ. ｇｏｖ. ｃｎ / ｘｉｎｗｅｎ / ２０１９－０７ / １５ / ｃｏｎｔｅｎｔ＿５４０９６９４.ｈｔｍ. Ｓｔａｔｅ Ｃｏｕｎｃｉｌ ｏｆ ｔｈｅ Ｐｅｏｐｌｅ'ｓ Ｒｅｐｕｂｌｉｃ ｏｆ Ｃｈｉｎａ. Ｈｅａｌｔｈｙ Ｃｈｉｎａ ａｃ￣ ｔｉｏｎ (２０１９－２０３０) [ＥＢ/ ＯＬ]. (２０１９－０７－１５) [ ２０２０－０３－０２]. ｈｔｔｐ: / / ｗｗｗ.ｇｏｖ.ｃｎ / ｘｉｎｗｅｎ / ２０１９－０７ / １５ / ｃｏｎｔｅｎｔ＿５４０９６９４.ｈｔｍ. [６０] 中华人民共和国国家卫生健康委员会. 关于印发健康中国行 动———癌症防治实施方案( ２０１９－ ２０２２ 年) 的通知[ ＥＢ/ ＯＬ]. (２０１９－０９－ ２３) [ ２０２０ － ０３ － ０２]. ｈｔｔｐ: / / ｗｗｗ. ｎｈｃ. ｇｏｖ. ｃｎ / ｊｋｊ / ｓ５８７８ / ２０１９０９ / ２ｃｂ５ｄｆｂ５ｄ４ｆ８４ｆ８８８１８９７ｅ２３２ｂ３７６ｂ６０.ｓｈｔｍｌ. Ｎａｔｉｏｎａｌ Ｈｅａｌｔｈ Ｃｏｍｍｉｓｓｉｏｎ ｏｆ ｔｈｅ Ｐｅｏｐｌｅ 'ｓ Ｒｅｐｕｂｌｉｃ ｏｆ Ｃｈｉｎａ. Ｎｏｔｉｃｅ ｏｎ ｐｒｉｎｔｉｎｇ ａｎｄ ｄｉｓｔｒｉｂｕｔｉｎｇ ｈｅａｌｔｈ Ｃｈｉｎａ ａｃｔｉｏｎ － ｃａｎｃｅｒ ｐｒｅｖｅｎｔｉｏｎ ａｎｄ ｃｏｎｔｒｏｌ ｉｍｐｌｅｍｅｎｔａｔｉｏｎ ｐｌａｎ (２０１９ － ２０２２) [ＥＢ/ ＯＬ]. (２０１９－９－ ２３) [ ２０２０ － ３ － ０２]. ｈｔｔｐ: / / ｗｗｗ. ｎｈｃ. ｇｏｖ. ｃｎ / ｊｋｊ / ｓ５８７８ / ２０１９０９ / ２ｃｂ５ｄｆｂ５ｄ４ｆ８４ｆ８８８１８９７ｅ２３２ｂ３７６ｂ６０.ｓｈｔｍｌ. (收稿日期:２０２０－０３－１９) (修回日期:２０２０－０４－０１) 本文编辑:范安琪(中文) 潘海峰(英文) 中华疾病控制杂志 ２０２０ 年 ４ 月第 ２４ 卷第 ４ 期 Ｃｈｉｎ Ｊ Ｄｉｓ Ｃｏｎｔｒｏｌ Ｐｒｅｖ ２０２０ Ａｐｒꎻ ２４(４) 􀅰３７９􀅰